New study aims to uncover hidden liver risks of immunotherapy drugs
NCT ID NCT04476563
First seen Sep 30, 2025 · Last updated May 11, 2026 · Updated 30 times
Summary
This study looks at liver injury caused by checkpoint inhibitor drugs used in cancer treatment. Researchers will follow 160 people to find out how common this side effect is and what makes some people more likely to get it. They will also test blood samples for new markers that could help diagnose the condition earlier and more accurately.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNE-MEDIATED HEPATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Nottingham
RECRUITINGNottingham, NG72RD, United Kingdom
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.